Pirarubicin Hydrochloride is an anthracycline antineoplastic antibiotic and a synthetic analogue of doxorubicin, primarily utilized in chemotherapy for the treatment of solid tumors such as breast cancer,… Read more
Pirarubicin Hydrochloride is an anthracycline antineoplastic antibiotic and a synthetic analogue of doxorubicin, primarily utilized in chemotherapy for the treatment of solid tumors such as breast cancer, osteosarcoma, and soft tissue sarcomas. This agent functions by intercalating into DNA and inhibiting topoisomerase II, effectively preventing cell replication and inducing apoptosis in malignant cells. Accurate analytical assessment of this drug requires precise reference materials to ensure reliable quality control and regulatory compliance. This category contains high-quality Pirarubicin Hydrochloride reference standards, including pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories to perform rigorous impurity profiling, validate analytical methods, and ensure the consistent therapeutic efficacy and safety of drug products during development and manufacturing processes.